WTW 2026 Best Practices in Healthcare Survey: U.S. employer healthcare costs set to rise at fastest pace in more than two decades
Most surveyed employers favor multiyear solutions over immediate savings, with 80% preferring that approach.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
WTW (NASDAQ: WTW) released survey findings showing U.S. employers expect healthcare cost growth to reach its fastest pace since the early 2000s.
Employers project costs will rise 11.1% in 2027 before plan changes and 9.7% after changes. Pharmacy costs are expected to increase 11.5% in 2026, versus 9% in 2025. High-cost claimants and pharmacy spending were cited as cost pressures by 86% and 83% of employers, respectively.
49% say significant healthcare program changes will be needed within three years, up from 34% last year. Coverage of GLP-1 drugs for weight loss declined from 57% to 53%; 30% of employers retaining coverage are considering eliminating it. By 2028, 85% are planning or considering shifting costs through employee premium contributions, versus 44% doing so today. Meanwhile, 84% are planning or considering taking health plans or vendors out to bid, up from 39% today.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Pharmacy costs climb
NEW YORK, Oct. 28, 2026 (GLOBE NEWSWIRE) -- High-cost claimants and pharmacy spending are the leading healthcare cost pressures facing U.S. employers, cited by
The pressure extends across healthcare spending. U.S. employers project healthcare costs will rise
Pharmacy costs are expected to increase
Nearly half of employers (
“Pharmacy has moved from a line item to the center of the healthcare cost conversation,” said Jeff Levin-Scherz, Population Health Leader, North America, WTW. “GLP-1s, specialty drugs and gene therapies can change patients’ lives, but the costs of these advances are hard to sustain. Removing coverage outright tends to fall hardest on the employees with the most to gain. Before making coverage changes, employers should consider clinical programs, risk protection such as stop-loss and lower-cost purchasing channels.”
The findings show employers are also rethinking both drug coverage and the vendors that manage it:
- GLP-1 coverage for weight loss declined for the first time in three years, from
57% of employers to53% . Of those who still cover them,30% are considering eliminating coverage. Among employers that have dropped or are weighing dropping coverage,91% cite cost as a reason. - The Net Promoter Score for pharmacy benefit managers (PBMs) fell from -10 in 2024 to -25 in 2026. Nearly two thirds of employers (
64% ) have taken, are planning or are considering action on their PBM relationships, such as taking services out to bid or using an alternative PBM.
Employees are likely to pay more.
Employers expect to ask employees to shoulder a larger share of healthcare costs over the next two years. Among U.S. employers surveyed:
85% are planning or considering shifting costs through employee premium contributions by 2028, nearly double the44% doing so today.71% are planning or considering shifting costs through out-of-pocket expenses, up from30% .41% are planning or considering eliminating some generous coverage provisions, almost four times the11% doing so today.
At the same time, employers remain cautious about changes that could disrupt employees. Six in ten (
Employers are weighing bigger changes.
Most employers prefer a measured approach, with
22% are planning or considering restricting eligibility, up from13% today.63% are planning or considering lower out-of-pocket costs for using high value providers, those with higher quality and lower costs, triple the21% doing so today.
Healthcare vendors and programs can expect scrutiny and will need to prove their value.
With costs remaining elevated, employers are increasingly examining whether existing programs and vendors are delivering sufficient value. Looking ahead to 2028:
84% are planning or considering taking health plans or vendors out to bid, up from39% today.55% are planning or considering evaluating fraud, waste and abuse, up from23% .38% are planning or considering cutting back the number of vendors they use, up from14% .
The average employer now works with 13 health and wellbeing vendors, up from 11 in 2022. Yet only a third of employers (
“Plan design tweaking and cost-shifting can’t meet the objective,” said Courtney Stubblefield, Strategy & Specialty Leader, Health & Benefits, WTW. “Employers need a multi-year strategy with finance at the table that delivers a proactive plan for pharmacy and other high-cost risks and holds vendors accountable for results. Employers should start by asking whether they are getting enough value from the money already being spent.”
The complete findings are available in the WTW 2026 Best Practices in Healthcare report.
About the survey
The WTW Best Practices in Healthcare Survey, now in its 30th year, was conducted between June 22 and August 7, 2026. The 2026 survey is based on responses from 471 U.S. employers with at least 100 employees, together employing 7 million people. Healthcare trend figures are medians. Employee figures cited are from the WTW 2026 Global Benefits Attitudes Survey, based on responses from 6,000 full-time U.S. employees collected between February and May 2026.
About WTW
At WTW (NASDAQ: WTW), we provide data-driven, insight-led solutions in the areas of people, risk and capital. Leveraging the global view and local expertise of our colleagues serving 140 countries and markets, we help organizations sharpen their strategy, enhance organizational resilience, motivate their workforce and maximize performance. Working shoulder to shoulder with our clients, we uncover opportunities for sustainable success, and provide perspective that moves you. Learn more at wtwco.com.
Media contacts
Abby Cosenza, Pierpont, acosenza@piercom.com, 214.998.0658
Ileana Feoli: Ileana.feoli@wtwco.com, 212.309.5504
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How much do employers expect healthcare costs to rise in WTW’s 2026 survey?
U.S. employers project healthcare costs will rise 11.1% in 2027 before plan changes and 9.7% after changes. Separately, pharmacy costs are expected to increase 11.5% in 2026, up from 9% in 2025.
How is employer coverage of GLP-1 weight-loss drugs changing in WTW’s survey?
Employer coverage of GLP-1 drugs for weight loss declined from 57% to 53%, the first decline in three years. Among employers still providing coverage, 30% are considering eliminating it. Of employers that have dropped or are weighing dropping coverage, 91% cite cost as a reason.
How many employers in WTW’s survey assess their healthcare point solutions’ results?
34% of employers evaluate the clinical impact of their point solutions, while 42% evaluate the financial impact. Employers now work with an average of 13 health and wellbeing vendors, up from 11 in 2022.